# Rizatriptan 10 MG RPD in the Treatment of Acute Migraine

> **NCT01057160** · PHASE4 · COMPLETED · sponsor: **Universität Duisburg-Essen** · enrollment: 195 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Rizatriptan

## Key facts

- **NCT ID:** NCT01057160
- **Lead sponsor:** Universität Duisburg-Essen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 195 (ACTUAL)
- **Last updated:** 2013-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01057160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01057160, "Rizatriptan 10 MG RPD in the Treatment of Acute Migraine". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01057160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*